Related content

Thyroid-associated ophthalmopathy in black South Africans with Graves' disease: Relationship to serum antibodies reactive against eye muscle and orbital connective tissue autoantigens

By Joffe Barry   Panz Vanessa   Yamada Masayo   Wall Jack  

Endocrine Journal, Vol. 13, Iss. 3, 2000-12 ,pp. : 325-328

Humana Press, Inc

Access to resources Recommend Favorite

Thyroid Hormones, Their Carrier Proteins, and Thyroid Antibodies in the Pleural Effusion of Two Patients with Graves' Disease-induced Thyrotoxicosis

By Kinoshita Hiroyuki   Yasuda Mutsuko   Kaneko Shingo   Usui Ryo   Inoshita Seiji   Furumoto Youhei   Maruyama Yasuki   Susa Koichiro   Suenaga Matsuhiko   Fujita Hiroshi   Tomiyama Junji   Yakushiji Fumiatsu  

Endocrine Research, Vol. 35, Iss. 4, 2010-11 ,pp. : 183-187

Informa Healthcare

Access to resources Recommend Favorite

Determination of the Levels of Anti-Thyroid-Stimulating Hormone Receptor Antibody with Thyroid Peroxidase Antibody in Omani Patients with Graves’ Disease

By  

Medical Principles and Practice, Vol. 14, Iss. 4, 2005-06 ,pp. : 209-212

Karger

Access to resources Recommend Favorite

The role of cytokeratin 19 in the differential diagnosis of true papillary carcinoma of thyroid and papillary carcinoma-like changes in Graves’ disease

By Erkiliç Suna   Koçer N.  

Endocrine Pathology, Vol. 16, Iss. 1, 2005-03 ,pp. : 63-66

Humana Press, Inc

Access to resources Recommend Favorite

Simultaneous diffuse sclerosis variant of papillary thyroid carcinoma and diffuse toxic hyperplasia (Graves’ disease)

By Paner Gladell   Hunt Jennifer   Ciesla Marlyn   DeJong Steven   LiVolsi Virginia  

Endocrine Pathology, Vol. 15, Iss. 1, 2004-03 ,pp. : 77-82

Humana Press, Inc

Access to resources Recommend Favorite